GelMEDIX
Develops regenerative therapies to restore vision by regenerating damaged retinal cells
$13MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Develops regenerative therapies to restore vision by regenerating damaged retinal cells
Provides upgrades to existing nuclear plants to increase electrical generation capacity
Pitching Safar Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room